Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial
Martin E Gore,Clare L Griffin,Barry Hancock,Poulam M Patel,Lynda Pyle,Michael Aitchison,Nicholas James,Roderick TD Oliver,Jozef Mardiak,Tahera Hussain,Richard Sylvester,Mahesh KB Parmar,Patrick Royston,Peter FA Mulders
20–26 February 2010
Copyright © 2010, Elsevier
Welcome to RightsLink
Elsevier has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Elsevier content. Select the "I would like to ..." drop-down menu to view the many reuse options available to you.
I would like to...
To request permission for a type of use not listed, please contact Elsevier Global Rights Department.Are you the author of this Elsevier journal article?
Clearance Center, Inc. All Rights Reserved.
Comments? We would like to hear from you. E-mail us at